COVID-19-driven Endothelial Damage: Complement, HIF-1, and ABL2 Are Potential Pathways of Damage and Targets for Cure

Overview

Journal Ann Hematol

Specialty Hematology

Date 2020 Jun 26

PMID 32583086

Citations 75

Authors

Monia Marchetti

Affiliations

Soon will be listed here.

Abstract

COVID-19 pandemia is a major health emergency causing hundreds of deaths worldwide. The high reported morbidity has been related to hypoxia and inflammation leading to endothelial dysfunction and aberrant coagulation in small and large vessels. This review addresses some of the pathways leading to endothelial derangement, such as complement, HIF-1α, and ABL tyrosine kinases. This review also highlights potential targets for prevention and therapy of COVID-19-related organ damage and discusses the role of marketed drugs, such as eculizumab and imatinib, as suitable candidates for clinical trials.

Citing Articles

A KSHV-targeted small molecule efficiently blocks SARS-CoV-2 infection via inhibiting expression of EGFR and Cyclin A2.

Dong Z, Wang X, Hu G, Huang Q, Zhang Y, Jia Y Emerg Microbes Infect. 2024; 14(1):2440490.

PMID: 39655540 PMC: 11660446. DOI: 10.1080/22221751.2024.2440490.

Is there a rationale for hyperbaric oxygen therapy in the patients with Post COVID syndrome? : A critical review.

Pawlik M, Rinneberg G, Koch A, Meyringer H, Loew T, Kjellberg A Eur Arch Psychiatry Clin Neurosci. 2024; 274(8):1797-1817.

PMID: 39545965 PMC: 11579208. DOI: 10.1007/s00406-024-01911-y.

Genetic and epigenetic regulation of cortactin (CTTN) by inflammatory factors and mechanical stress in human lung endothelial cells.

Sun X, Sun B, Sammani S, Dudek S, Belvitch P, Camp S Biosci Rep. 2024; 44(9).

PMID: 39162263 PMC: 11405783. DOI: 10.1042/BSR20231934.

The mechanistic basis linking cytokine storm to thrombosis in COVID-19.

Wolf A, Khimani F, Yoon B, Gerhart C, Endsley D, Ray A Thromb Update. 2024; 8:100110.

PMID: 38620974 PMC: 9116969. DOI: 10.1016/j.tru.2022.100110.

Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID.

Naidu A, Wang C, Rao P, Mancini F, Clemens R, Wirakartakusumah A NPJ Sci Food. 2024; 8(1):19.

PMID: 38555403 PMC: 10981760. DOI: 10.1038/s41538-024-00261-2.

References

Lippi G, Plebani M, Henry B . Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta. 2020; 506:145-148. PMC: 7102663. DOI: 10.1016/j.cca.2020.03.022. View

Carnevale-Schianca F, Gallo S, Rota-Scalabrini D, Sangiolo D, Fizzotti M, Caravelli D . Complete resolution of life-threatening bleomycin-induced pneumonitis after treatment with imatinib mesylate in a patient with Hodgkin's lymphoma: hope for severe chemotherapy-induced toxicity?. J Clin Oncol. 2011; 29(24):e691-3. DOI: 10.1200/JCO.2011.35.6733. View

Lu K, Zhao J, Liu W . Macrophage stimulating 1-induced inflammation response promotes aortic aneurysm formation through triggering endothelial cells death and activating the NF-κB signaling pathway. J Recept Signal Transduct Res. 2020; 40(4):374-382. DOI: 10.1080/10799893.2020.1738484. View

Gupta N, Zhao Y, Evans C . The stimulation of thrombosis by hypoxia. Thromb Res. 2019; 181:77-83. DOI: 10.1016/j.thromres.2019.07.013. View

Li X, Fang P, Sun Y, Shao Y, Yang W, Jiang X . Anti-inflammatory cytokines IL-35 and IL-10 block atherogenic lysophosphatidylcholine-induced, mitochondrial ROS-mediated innate immune activation, but spare innate immune memory signature in endothelial cells. Redox Biol. 2019; 28:101373. PMC: 6920093. DOI: 10.1016/j.redox.2019.101373. View

Kimura Y, Inoue K, Abe M, Nearman J, Baranowska-Kortylewicz J . PDGFRbeta and HIF-1alpha inhibition with imatinib and radioimmunotherapy of experimental prostate cancer. Cancer Biol Ther. 2007; 6(11):1763-72. DOI: 10.4161/cbt.6.11.4854. View

Collum S, Chen N, Hernandez A, Hanmandlu A, Sweeney H, Mertens T . Inhibition of hyaluronan synthesis attenuates pulmonary hypertension associated with lung fibrosis. Br J Pharmacol. 2017; 174(19):3284-3301. PMC: 5595757. DOI: 10.1111/bph.13947. View

Dyall J, Coleman C, Hart B, Venkataraman T, Holbrook M, Kindrachuk J . Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrob Agents Chemother. 2014; 58(8):4885-93. PMC: 4136000. DOI: 10.1128/AAC.03036-14. View

Fenocchio E, Depetris I, Campanella D, Garetto L, Carnevale Schianca F, Galizia D . Successful treatment of gemcitabine-induced acute interstitial pneumonia with imatinib mesylate: a case report. BMC Cancer. 2016; 16(1):793. PMC: 5059971. DOI: 10.1186/s12885-016-2833-9. View

10.

Dolmatova E, Wang K, Mandavilli R, Griendling K . The effects of sepsis on endothelium and clinical implications. Cardiovasc Res. 2020; 117(1):60-73. PMC: 7810126. DOI: 10.1093/cvr/cvaa070. View

11.

Shrivastava G, Visoso-Carvajal G, Garcia-Cordero J, Leon-Juarez M, Chavez-Munguia B, Lopez T . Dengue Virus Serotype 2 and Its Non-Structural Proteins 2A and 2B Activate NLRP3 Inflammasome. Front Immunol. 2020; 11:352. PMC: 7076137. DOI: 10.3389/fimmu.2020.00352. View

12.

Suresh M, Balijepalli S, Zhang B, Singh V, Swamy S, Panicker S . Hypoxia-Inducible Factor (HIF)-1α Promotes Inflammation and Injury Following Aspiration-Induced Lung Injury in Mice. Shock. 2019; 52(6):612-621. PMC: 6591116. DOI: 10.1097/SHK.0000000000001312. View

13.

Chan J, Lau S, To K, Cheng V, Woo P, Yuen K . Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev. 2015; 28(2):465-522. PMC: 4402954. DOI: 10.1128/CMR.00102-14. View

14.

Pang R, Poon T, Chan K, Lee N, Chiu R, Tong Y . Serum proteomic fingerprints of adult patients with severe acute respiratory syndrome. Clin Chem. 2006; 52(3):421-9. PMC: 7108167. DOI: 10.1373/clinchem.2005.061689. View

15.

Schmitt F, Manolov V, Morgenstern J, Fleming T, Heitmeier S, Uhle F . Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot study. Ann Intensive Care. 2019; 9(1):19. PMC: 6353981. DOI: 10.1186/s13613-019-0499-6. View

16.

Sun S, Zhao G, Liu C, Wu X, Guo Y, Yu H . Inhibition of complement activation alleviates acute lung injury induced by highly pathogenic avian influenza H5N1 virus infection. Am J Respir Cell Mol Biol. 2013; 49(2):221-30. DOI: 10.1165/rcmb.2012-0428OC. View

17.

Sato H, Sugimura K, Miura M, Konno R, Kozu K, Yaoita N . Beneficial Effects of Imatinib in a Patient with Suspected Pulmonary Veno-Occlusive Disease. Tohoku J Exp Med. 2019; 247(2):69-73. DOI: 10.1620/tjem.247.69. View

18.

Xu P, Zhou Q, Xu J . Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol. 2020; 99(6):1205-1208. PMC: 7156897. DOI: 10.1007/s00277-020-04019-0. View

19.

Chen X, Ruan C, Ge Q, Ma Y, Xu J, Zhang Z . Deficiency of Complement C3a and C5a Receptors Prevents Angiotensin II-Induced Hypertension via Regulatory T Cells. Circ Res. 2018; 122(7):970-983. DOI: 10.1161/CIRCRESAHA.117.312153. View

20.

Moussa M, Santonocito C, Fagnoul D, Donadello K, Pradier O, Gaussem P . Evaluation of endothelial damage in sepsis-related ARDS using circulating endothelial cells. Intensive Care Med. 2014; 41(2):231-8. DOI: 10.1007/s00134-014-3589-9. View